$355 Million is the total value of TANG CAPITAL MANAGEMENT LLC's 11 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 18.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RCKT | Sell | ROCKET PHARMACEUTICALS INC | $112,336,000 | -30.9% | 2,531,800 | -14.6% | 31.61% | +27.3% |
| ANAB | ANAPTYSBIO INC | $56,648,000 | +0.2% | 2,628,678 | 0.0% | 15.94% | +84.7% | |
| APVO | APTEVO THERAPEUTICS INC | $53,715,000 | -16.7% | 1,760,000 | 0.0% | 15.11% | +53.5% | |
| ODT | ODONATE THERAPEUTICS INC | $53,060,000 | -82.2% | 15,514,566 | 0.0% | 14.93% | -67.2% | |
| LJPC | LA JOLLA PHARMACEUTICAL CO | $39,879,000 | +9.3% | 9,405,490 | 0.0% | 11.22% | +101.4% | |
| VINC | New | VINCERX PHARMA INC | $9,650,000 | – | 500,000 | +100.0% | 2.72% | – |
| CHRS | COHERUS BIOSCIENCES INC | $9,497,000 | -15.9% | 650,000 | 0.0% | 2.67% | +54.9% | |
| RLMD | RELMADA THERAPEUTICS INC | $7,042,000 | +9.8% | 200,000 | 0.0% | 1.98% | +102.3% | |
| BCTG | BCTG ACQUISITION CORP | $5,213,000 | -2.8% | 468,750 | 0.0% | 1.47% | +79.1% | |
| EQ | EQUILLIUM INC | $4,290,000 | +33.6% | 600,000 | 0.0% | 1.21% | +146.3% | |
| VINCW | Buy | VINCERX PHARMA INC*w exp 12/24/202 | $4,098,000 | +276.0% | 1,014,368 | +207.2% | 1.15% | +594.6% |
| VINCU | Exit | VINCERA PHARMA INCunit 12/24/2025 | $0 | – | -500,000 | -100.0% | -1.47% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HERON THERAPEUTICS INC | 37 | Q3 2023 | 55.0% |
| LA JOLLA PHARMACEUTICAL CO | 34 | Q2 2022 | 37.1% |
| ROCKET PHARMACEUTICALS INC | 20 | Q3 2023 | 31.6% |
| BIOMARIN PHARMACEUTICAL INC | 18 | Q3 2017 | 12.1% |
| ODONATE THERAPEUTICS INC | 17 | Q4 2021 | 69.8% |
| ANAPTYSBIO INC | 16 | Q3 2023 | 18.4% |
| COHERUS BIOSCIENCES INC | 15 | Q3 2023 | 2.7% |
| EQUILLIUM INC | 13 | Q3 2023 | 1.2% |
| RELMADA THERAPEUTICS INC | 12 | Q4 2022 | 6.2% |
| MIRATI THERAPEUTICS INC | 11 | Q3 2023 | 10.9% |
View TANG CAPITAL MANAGEMENT LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-14 |
| 4 | 2024-02-02 |
| 4 | 2023-12-18 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-10-13 |
| 13F-HR | 2023-08-14 |
| 3 | 2023-06-01 |
| 4 | 2023-06-01 |
| 4 | 2023-05-30 |
View TANG CAPITAL MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.